Vat-Cit-PAB-Monomethyl Dolastatin 10 structure
|
Common Name | Vat-Cit-PAB-Monomethyl Dolastatin 10 | ||
---|---|---|---|---|
CAS Number | 1415329-13-3 | Molecular Weight | 1176.512 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 1237.2±65.0 °C at 760 mmHg | |
Molecular Formula | C60H93N11O11S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 702.0±34.3 °C |
Use of Vat-Cit-PAB-Monomethyl Dolastatin 10Vat-Cit-PAB-Monomethyl Dolastatin 10 is a drug-linker conjugate for ADC with potent antitumor activity by using Monomethyl Dolastatin 10 (a potent tubulin inhibitor), linked via the ADC linker Vat-Cit-PAB. |
Name | VAL-CIT-PAB-MMAD |
---|---|
Synonym | More Synonyms |
Description | Vat-Cit-PAB-Monomethyl Dolastatin 10 is a drug-linker conjugate for ADC with potent antitumor activity by using Monomethyl Dolastatin 10 (a potent tubulin inhibitor), linked via the ADC linker Vat-Cit-PAB. |
---|---|
Related Catalog | |
Target |
Auristatin |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 1237.2±65.0 °C at 760 mmHg |
Molecular Formula | C60H93N11O11S |
Molecular Weight | 1176.512 |
Flash Point | 702.0±34.3 °C |
Exact Mass | 1175.677612 |
LogP | 6.49 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.564 |
L-Ornithinamide, L-valyl-N5-(aminocarbonyl)-N-[4-[(5S,8S,11S,12R)-12-[2-[(2R)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-2-oxoethyl]-4,1 0-dimethyl-5,8-bis(1-methylethyl)-11-[(1S)-1-methylpropyl]-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl]- |
L-Valyl-N-{4-[(5S,8S,11S,12R)-11-[(2S)-2-butanyl]-5,8-diisopropyl-12-(2-{(2R)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]-1-pyrrolidinyl}-2-oxoethyl)- ;4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl}-N5-carbamoyl-L-ornithinamide |